Skip to main content
. 2019 Apr 25;19:39. doi: 10.1186/s12902-019-0364-5

Table 2.

Diabetes Complications per treatment strategy at current period

Complication n (%) Total Treatment Strategy P
A B C
Acute complications 15 (3.7%) 2 (0.5%) 1 (0.2%) 12 (2.9%) NA
Non-ketotic Hyperglycaemic Hyperosmolar Coma 2 (0.2%) 1 (0.4%) 0 (0%) 1 (0.2%) NA
Infections 2 (0.2%) 0 (0%) 0 (0%) 2 (0.4%) NA
Diabetes-associated Hospitalisation 3 (0.3%) 0 (0%) 0 (0%) 3 (0,6%) NA
Other 7 (0.6%) 1 (0.4%) 1 (0.2%) 5 (1.1%) NA
Chronic complications 386 (32.5%) 29 (12.0%) 130 (27.2%) 227 (48.3%)
Diabetic Retinopathy 141 (11.9%) 6 (2.5%) 36 (7.5%) 99 (21.1%) < 0.001
Diabetic Nephropathy 140 (11.8%) 16 (6.6%) 43 (9.0%) 81 (17.2%) < 0.001
Diabetic Neuropathy 136 (11.4%) 7 (2.9%) 33 (6.9%) 96 (20.4%) < 0.001
Diabetic Foot: ulcers 14 (1.2%) 1 (0.4%) 6 (1.3%) 7 (1.5%) NA
Diabetic Foot: extensive superficial lesions 7 (0.6%) 1 (0.4%) 3 (0.6%) 3 (0.6%) NA
Diabetic Foot: gangrene 2 (0.2%) 0 (0%) 0 (0%) 2 (0.4%) NA
Diabetic Foot: lower extremity amputation 3 (0.3%) 0 (0%) 0 (0%) 3 (0.6%) NA
Cardiovascular events 69 (5.8%) 4 (1.7%) 29 (6.1%) 36 (7.7%) 0.005
Carotid Artery Disease 24 (2.0%) 3 (1.2%) 2 (0.4%) 19 (4.0%) < 0.001
Peripheral Arterial Disease 48 (4%) 3 (1.2%) 12 (2.5%) 33 (7%) < 0.001
Other 23 (1.9%) 2 (0.8%) 7 (1.5%) 14 (3%) 0.09